Correlation Between Dyadic International and Voyager Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dyadic International and Voyager Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyadic International and Voyager Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyadic International and Voyager Therapeutics, you can compare the effects of market volatilities on Dyadic International and Voyager Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyadic International with a short position of Voyager Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyadic International and Voyager Therapeutics.
Diversification Opportunities for Dyadic International and Voyager Therapeutics
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Dyadic and Voyager is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Dyadic International and Voyager Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Voyager Therapeutics and Dyadic International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyadic International are associated (or correlated) with Voyager Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Voyager Therapeutics has no effect on the direction of Dyadic International i.e., Dyadic International and Voyager Therapeutics go up and down completely randomly.
Pair Corralation between Dyadic International and Voyager Therapeutics
Given the investment horizon of 90 days Dyadic International is expected to generate 1.42 times more return on investment than Voyager Therapeutics. However, Dyadic International is 1.42 times more volatile than Voyager Therapeutics. It trades about 0.24 of its potential returns per unit of risk. Voyager Therapeutics is currently generating about -0.05 per unit of risk. If you would invest 114.00 in Dyadic International on September 13, 2024 and sell it today you would earn a total of 48.00 from holding Dyadic International or generate 42.11% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Dyadic International vs. Voyager Therapeutics
Performance |
Timeline |
Dyadic International |
Voyager Therapeutics |
Dyadic International and Voyager Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Dyadic International and Voyager Therapeutics
The main advantage of trading using opposite Dyadic International and Voyager Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyadic International position performs unexpectedly, Voyager Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Voyager Therapeutics will offset losses from the drop in Voyager Therapeutics' long position.Dyadic International vs. Werewolf Therapeutics | Dyadic International vs. Edgewise Therapeutics | Dyadic International vs. Celcuity LLC | Dyadic International vs. C4 Therapeutics |
Voyager Therapeutics vs. Puma Biotechnology | Voyager Therapeutics vs. Iovance Biotherapeutics | Voyager Therapeutics vs. Sarepta Therapeutics | Voyager Therapeutics vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Equity Valuation Check real value of public entities based on technical and fundamental data |